Publication

Combating HIV Type 1 with Peptide - Synthetic Polymer Conjugates

Related publications (71)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Combating HIV Type 1 with Peptide - Synthetic Polymer Conjugates

Graph Chatbot

Chat with Graph Search

High-temperature radical polymerization of methyl methacrylate in a continuous pilot scale process

Development of a novel drug delivery system based on polymeric, thermoresponsive, hydrogel nanoparticles

Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients

Synthesis and characterization of thermoresponsive polymers, hydrogels and microgels, based on poly(N-substituted acrylamides)

Lentiviral vectors interfering with virus-induced CD4 down-modulation potently block human immunodeficiency virus type 1 replication in primary lymphocytes

APOBEC3G Genetic Variants and Their Influence on the Progression to AIDS

Peptide/protein hybrid materials: Enhanced control of structure and improved performance through conjugation of biological and synthetic polymers

Towards a fully synthetic substitute of alginate: Optimization of a thermal gelation/chemical cross-linking scheme ("tandem" gelation) for the production of beads and liquid-core capsules

Directed expression of the HIV-1 accessory protein Vpu in Drosophila fat-body cells inhibits Toll-dependent immune responses

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts